Healthy growth in India, US helps Dr Reddy's post strong Q2 performance

Wockhardt buy, Covid portfolio aid India business growth

Healthy growth in key markets helped Dr Reddy’s post strong operating performance in the September quarter. 

Though Q2 numbers were lower on a year-on-year basis, the corresponding quarter last year had seen one-off gains. The reported numbers, however, came in ahead of analyst expectations.

Improved traction in the US was evident from North America’s 28 per cent growth, led by new products launches, increase in volumes of existing products, and a favorable forex rate. 

Gains on account of higher sales were partially offset by price erosion. The US is the single largest geography for Dr Reddy’s, accounting for 37 per